Risk of Poststroke Dementia in Patients With and Without Atrial Fibrillation: A Nationwide Cohort Study

伴有和不伴有房颤的卒中后痴呆风险:一项全国性队列研究

阅读:1

Abstract

BACKGROUND: Atrial fibrillation (AF) is associated with an increased risk of dementia in nonstroke populations. We aimed to study whether AF was also associated with an increased risk of poststroke dementia (PSD). METHODS: This nationwide register-based cohort study included all patients with incident acute ischemic stroke (AIS) in Denmark from 2008 to 2017. Patients with AF were compared with patients without AF using propensity-score weighting. The primary outcome was PSD, determined as a diagnosis of dementia or use of dementia medication within 5 years from AIS. PSD hazard rates were compared between patients with and without AF using Cox proportional hazards regression. Dementia-free mortality risk was evaluated as a secondary outcome. RESULTS: We included 61 058 patients with incident AIS, 12 248 with AF, and 48 810 without AF. Mean±SD age was 70.5±11.6, and 56.1% were men. A total of 3190 patients were diagnosed with dementia within a median of 2.1 (interquartile range, 0.82-4.2) years after AIS. In the unadjusted analysis, patients with AF had a higher PSD rate than patients without AF (19.0/1000 person-years versus 11.5/1000 person-years; hazard ratio [HR], 1.63 [95% CI, 1.51-1.77]). After adjustment for confounding factors, PSD risk was comparable between patients with and without AF (HR, 1.07 [95% CI, 0.97-1.17]). Dementia-free mortality risk was higher for patients with AF than patients without in both unadjusted (HR, 2.14 [95% CI, 2.07-2.21]) and adjusted analyses (HR, 1.31 [95% CI, 1.26-1.37]). CONCLUSIONS: Among patients with AIS, AF was not associated with an increased risk of PSD, likely due to an increased mortality risk. Patients with AF may not be a particular PSD high-risk group.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。